Sugi Predict

Sugi Predict / Compounds / SCHEMBL2163344

SCHEMBL2163344

SCHEMBL2163344

CC(Nc1ncnc2[nH]cnc12)c1cc(Cl)c2cccnc2c1N1CCN(C(=O)N(C)C)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 3/20 0.43
▸ L3MBTL1 Q9Y468 4/20 0.40
▸ NPC1 O15118 7/20 0.38
▸ RAB9A P51151 7/20 0.38
▸ ALOX12 P18054 4/20 0.37
▸ NCOA3 Q9Y6Q9 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ NCOA1 Q15788 1/20 0.35
▸ MEN1 O00255 4/20 0.35
▸ KMT2A Q03164 4/20 0.35
▸ MAPT P10636 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ MPI P34949 1/20 0.35
▸ HSP90AA1 P07900 5/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ PPP1CA P62136 1/20 0.34
▸ PSMD14 O00487 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL2164857 0.95 PIK3CD (0.42) PIK3CDL3MBTL1NPC1RAB9AALOX12
SCHEMBL2163953 0.91 PIK3CD (0.43) PIK3CDL3MBTL1NPC1RAB9AALOX12
SCHEMBL2164764 0.89 PIK3CD (0.42) PIK3CDL3MBTL1NPC1RAB9AALOX12
SCHEMBL2017857 0.89 PIK3CD (0.42) PIK3CDL3MBTL1NPC1RAB9AALOX12
SCHEMBL2017432 0.89 PIK3CD (0.42) PIK3CDL3MBTL1NPC1RAB9AALOX12
SCHEMBL2165010 0.89 PIK3CD (0.42) PIK3CDL3MBTL1NPC1RAB9AALOX12
SCHEMBL2164038 0.88 PIK3CD (0.42) PIK3CDL3MBTL1NPC1RAB9AALOX12
SCHEMBL2015619 0.88 PIK3CD (0.42) PIK3CDL3MBTL1NPC1RAB9AALOX12
SCHEMBL2013364 0.88 PIK3CD (0.42) PIK3CDL3MBTL1NPC1RAB9AALOX12
SCHEMBL12631373 0.87 PIK3CD (0.49) PIK3CDL3MBTL1NPC1RAB9AALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680108-B2 Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors INCYTE CORPORATION (US) 2014-03-25 — — US claimed
US-20110183985-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION 2011-07-28 — — US claimed
US-8680108-B2 Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors INCYTE CORPORATION (US) 2014-03-25 — — US disclosed
US-8680108-B2 Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors INCYTE CORPORATION (US) 2014-03-25 — — US disclosed
US-20110183985-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION 2011-07-28 — — US disclosed
US-20110183985-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION 2011-07-28 — — US disclosed
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183985-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS PIK3R1, PIK3R3, PIK3R2 PIK3CD 13/4885L3MBTL1 2960/4885NPC1 3274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.